FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046184 [Registered on: 04/10/2022] Trial Registered Prospectively
Last Modified On: 16/09/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical trial to study of Jyotishmatyadi churna and matra basti of Satpushpa tail in patients of Artavakshaya w.s.r. Oligo-Hypomenorhhea. 
Scientific Title of Study   A Comparative clinical study to evaluate the effect of Jyotishmatyadi churna alongwith Satpushpa taila Matra basti in the management of Artavakshaya wsr to Oligo-Hypomenorhhea 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gyan jyoti Chaudhary 
Designation  MS Ayurveda research scholar 
Affiliation  State Ayurvedic College and Hospital Lucknow UP 
Address  PG department of Prasuti tantra and Stri rog,State Ayurvedic college and hospital,Tulsidas Marg,Lucknow

Lucknow
UTTAR PRADESH
226004
India 
Phone  9140798293  
Fax    
Email  singhjyoti1483@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shashi Sharma 
Designation  Reader, PG Department of Prasuti Tantra and Stri Rog 
Affiliation  State Ayurvedic College and Hospital, Lucknow  
Address  PG department of Prasuti tantra and Stri rog ,State Ayurvedic College and Hospital ,Tulsidas Marg,Lucknow

Lucknow
UTTAR PRADESH
226004
India 
Phone  7068364242  
Fax    
Email  shashibedar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gyan jyoti Chaudhary 
Designation  MS Ayurveda research scholar 
Affiliation  State Ayurvedic College and Hospital, Lucknow  
Address  PG department of Prasuti tantra and Stri rog,State Ayurvedic College and Hospital,Tulsidas Marg,Lucknow

Lucknow
UTTAR PRADESH
226004
India 
Phone  9140798293  
Fax    
Email  singhjyoti1483@gmail.com  
 
Source of Monetary or Material Support  
State Ayurvedic College and Hospital Tulsidas Marg Lucknow 226004 
 
Primary Sponsor  
Name  State Ayurvedic College and Hospital Lucknow 
Address  State Ayurvedic College and Hospital Tulsidas Marg Lucknow UP 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gyan jyoti Chaudhary  State Ayurvedic College and Hospital Lucknow  OPD No 1 Department of Prasuti Tantra and Stri Rog State Ayurvedic College and Hospital Tulsidas Marg Lucknow
Lucknow
UTTAR PRADESH 
9140798293

singhjyoti1483@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee State Ayurvedic College and Hospital Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N915||Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Jyotishmatyadi churna, Reference: yog ratnakar (yoni vyapad roganamchikitsa), Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Milk), Additional Information: 3 consecutive cycles(2 cycles with trial drug and one cycle drug free follow up)after clearance of menses.
2Comparator ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Charak Samhita, Procedure details: Medication/Therapy will be given once in a day upto 9 days in one cycle after clearance of menses and same will be repeated in next cycle also.After that follow up will be done for 30 days. )
(1) Medicine Name: Satpushpa, Reference: Kashyap Samhita, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 18 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1- Patients between the age group of 18-40 years.
2- patients fulfilling cardinal symptoms of Artavakshaya.
3- patients willing to participate in the study with proper written consent.
 
 
ExclusionCriteria 
Details  1- patient having systemic diseases(HTN,TB,DM)
2- Thyroid disorder
3- Pregnant & lactating women
4- patient onOCPs,IUCD
5- Congenital anomalies of uterus or ovaries
6- Patient with any pelvic pathology or malignancy
7- PCOD
8- Hb% less than 10 gm 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1- To assess the efficacy of Jyotishmatyadi churna along with satpushpa taila Matra Basti inthe management of Artavakshaya.
2- To assess the efficacy of trial therapy on subjective parameters like interval between two cycle,duration of bleeding,amount of blood loss and pain during menstruation- assess with the help of VAS scale. 
3 consecutive cycle (2 cycle with trial drug and one cycle drug free follow up. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of trial therapy on subjective parameters like interval between two cycles,duration of bleeding,amount of blood loss and pain during Menstruation- assess with the help of VAS scale.  3 consecutive cycles (2 cycles with trial drug and one cycle drug free follow up ). 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/10/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study is entitled as – “A comparative clinical study to evaluate the effect Jyotishmatyadi churna

 alongwith Satpushpa taila Matra Basti in the management of Artavakshaya w.s.r. Oligo-Hypomenorrhea”.

 

Objective of study – To compare the efficacy of Jyotishmatyadi churna and Jyotishmatyadi churna

alongwith Satpushpa taila Matra Basti in the management of Artavakshaya w.s.r. Oligo-Hypomenorrhea.

 

Type of study – Randomized comparative open clinical trial.

 

Administration of trial therapy – Minimum 40 patient having cardinal symptoms of Artavakshaya will

registered into groups.

 

Group A – Jyotishmatyadi churna ( 3 gm ) twice a day with milk after meal ( after clearance of menses ).

 

Group B – Jyotishmatyadi churna ( 3 gm ) twice a day with milk after milk and Satpushpa taila Matra

Basti ( 60 ml ) once in a day for 9 days ( after clearance of menses ).

 

Duration of period – 3 consecutive cycles ( 2 cycles with trial drug and one cycle drug free follow up ).

 

Therapy period – 2 consecutive cycles after clearance of menses.

 

Follow up during treatment – On the clearance of each menstrual cycle during the period of treatment.

 

Criteria for selection of patient - 

 

Diagnostic criteria –   Diagnosis will be based on the presence of any one or more of the cardinal symptoms of Artavakshaya.

 

A.      Yathochitakala Adarshanam of Artava – Menstrual cycle > 35 days

B.      Alpartavam –

1.       Duration of bleeding < 2 days

2.       Decrease in quantity of Bleeding

C.      Yoni Vedana

 

Inclusion criteria –

 

1.    1  . Patients between age group of 18 – 40 years.

2.     2 . Patients fulfilling the cardinal symptoms of Artavakshaya.

3.     3 . Patients willing to participate in the study with proper written consent.

 

Exclusion criteria –

 

1.       Patient having systemic disease (HTN, TB , DM )

2.       Thyroid disorder

3.       Pregnant and Lactating women

4.       Patient on 0CPs , IUCD

5.       Congenital anomalies of uterus or ovaries

6.       Patient with any pelvic pathology or malignancy

7.       PCOD

8.       Hb% less than 10 gm

 

Investigation – At the time of registration.

 

1.       Hb%

2.       ESR

3.       FBS

4.       LFT

5.       Thyroid profile

6.       USG – Pelvic region ( Endometrial thickness )

7.       UPT

 

Assessment criteria –  Assessment will be done on the basis of improvement in the sign and symptoms

for the purpose.

Subjective criteria –

1.       Interval between two cycles

2.       Duration of bleeding

3.       Amount of blood loss

4.       Pain during menstruation – assess with the help of VAS scale

 
Close